: .
: :
o (100 / 2 0,3 1 2 )
o (100-150 / 2 )
o (1 / 1-2 , 0,2 2-3 )
: 3 , D-
: , .
.
, .
.
2 ,
.
. .
. .
.
36-38%, , .
.
.
.
:
;
o ;
o ;
o , .
: , .
: 3,5 ,
Cystofix 14-30
. .
.
.
: , ,
c .
1 2 :
|
|
(, , )
,
,
( , , , , )
( , )
.
1. . : / . .. , .. . 2- . . . .: -, 2010. . 517 539.
2. : / . .. , .. , .. . .: -, 2007. . 607 622.
3. .. / .. , .. , .. // - 1995. - N 1. - . 26-32.
4. : 2013 .
5. .. ./ .. , .. ., .. .// 2014 . - 8. N 3. - . 6-10.
6. E.G. Papanikolaou Identification of the High-Risk Patient for Ovarian Hyperstimulation Syndrome / E.G. Papanikolaou, P. Humaidan, N.P. Polyzos, B. Tarlatzis // Semin Reprod Med 2010. - 28(6). . 458-462.
7. Infertility and assisted reproduction / edited by B.R.M.B. Rizk et al. United States of America, Cambridge University Press, 2008. P. 604 618.
8. Zivi E. Ovarian Hyperstimulation Syndrome: Definition, Incidence, and Classification / E.Zivi, A.Simon, N. Laufer // Semin Reprod Med 2010. - 28(6). . 441-447.
9. ESHRE Capri Workshop Group. Venous tromboembolism in women: a specific reproductive health risk// Hum. Rep. Update 2013- Jul 3.
10. Ovarian hyperstimulation syndrome. Practice Committee of the American Society for Reproductive Medicine. //Fertil. Steril. - 2006 Nov; 86 (5 Suppl) P.S 178-83
11.Prevention of Ovarian Hyperstimulation Syndrome: A Review.
Smith V et all // Obstet Gynecol Int. 2015;Epub 2015 May 14.
12.Cabergoline for reducing ovarian hyperstimulation syndrome in assisted reproductive technology treatment cycles. A prospective randomized controlled trial. /Amir H. et all.//J Reprod Med. 2015 Jan-Feb;60(1-2):48-54.
13.Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology./Youssef MA et.all. //Cochrane Database Syst Rev. 2014 Oct 31;(10).
14. Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials./Leitao VM, Moroni RM, Seko LM//Fertil Steril. 2014 Mar;101(3):664-75.
15. The prevention of ovarian hyperstimulation syndrome./ Corbett S, Shmorgun D. et All//J Obstet Gynaecol Can. 2014 Nov;36(11):1024-36.